Maryland · 2026 Regular Session · Bill

SB 562: State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders

Enacted Last action April 14, 2026: Approved by the Governor - Chapter 54

Plain-language summary

SB 562 is a bill introduced in the Maryland Senate on February 4, 2026. According to its official title, it concerns: State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders. Primary sponsor: Dawn Gile (Democratic). Most recent recorded action (April 14, 2026): Approved by the Governor - Chapter 54.

Sponsors

Primary sponsor: Dawn Gile (Democratic).